🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Every year, 100,000 neonates are born with hemoglobinopathies around the wo...
Status
Completed
Location
Assiut University Hospital
Start Date
2018-08-01
Trial ID
NCT03170245
Treatments Being Tested
This phase II trial tests how well epcoritamab in combination with rituxima...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2026-07-27
Trial ID
NCT07365306
This is an open-label Phase I trial to evaluate the safety of a hematopoiet...
Status
Completed
Location
Stanford University
Start Date
2020-07-06
Trial ID
NCT04105166
Treatments Being Tested
This Long-Term Follow-Up (LTFU) for Gene Therapy of Leukocyte Adhesion Defi...
Status
Active Not Recruiting
Location
University of California, Los Angeles (UCLA)
Start Date
2022-03-09
Trial ID
NCT06282432
The primary purpose of the Phase I portion of the study is to assess the th...
Status
Completed
Location
University of California, Los Angeles
Start Date
2019-08-30
Trial ID
NCT03812263
Treatments Being Tested
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder and ...
Status
Unknown
Location
Second Department of Obstetrics and Gynecology, Third Department of Cardiology, Second Propedeutic Department of Internal Medicine, Aristotle University
Start Date
2011-04
Trial ID
NCT01392781
The primary purpose of the Phase I portion of the study is to determine the...
Status
Withdrawn
Location
Hospital Infantil Universitario Niño Jesús (HIUNJ)
Start Date
2019-04-15
Trial ID
NCT03825783
Treatments Being Tested
This is an open-label Phase II trial to evaluate the efficacy of a hematopo...
Status
Suspended
Location
Stanford University
Start Date
2026-04
Trial ID
NCT06422351
Treatments Being Tested
The primary objective of this Phase 1 study is to evaluate the therapeutic ...
Status
Terminated
Location
University of California, Los Angeles
Start Date
2020-11-19
Trial ID
NCT04525352
Treatments Being Tested
This phase II trial tests how well epcoritamab in combination with standard...
Status
Recruiting
Location
University of California Davis Comprehensive Cancer Center
Start Date
2025-07-31
Trial ID
NCT06905509